AAAAAA

   
Results: 1-7 |
Results: 7
ANTIBODIES TO EPSTEIN-BARR-VIRUS IN RELATION TO CLINICAL CHARACTERISTICS OF UNTREATED PATIENTS WITH HODGKINS-DISEASE
Authors: MERK K LENNETTE E HOLM G JOHANSSON B MASUCCI G GRIMFORS G KLEIN G BJORKHOLM M
Citation: K. Merk et al., ANTIBODIES TO EPSTEIN-BARR-VIRUS IN RELATION TO CLINICAL CHARACTERISTICS OF UNTREATED PATIENTS WITH HODGKINS-DISEASE, Cancer research, therapy & control, 4(3), 1995, pp. 223-229
FIRED VERSUS RESPONSE-ADAPTED MOPP ABVD CHEMOTHERAPY IN HODGKINS-DISEASE - A PROSPECTIVE RANDOMIZED TRIAL/
Authors: BJORKHOLM M AXDORPH U GRIMFORS G MERK K JOHANSSON B LANDGREN O SVEDMYR E MELLSTEDT H HOLM G
Citation: M. Bjorkholm et al., FIRED VERSUS RESPONSE-ADAPTED MOPP ABVD CHEMOTHERAPY IN HODGKINS-DISEASE - A PROSPECTIVE RANDOMIZED TRIAL/, Annals of oncology, 6(9), 1995, pp. 895-899
INCREASED SERUM CD4 SOLUBLE-ANTIGEN LEVEL IS ASSOCIATED WITH A POOR-PROGNOSIS IN ADULT HODGKINS-DISEASE
Authors: GRIMFORS G ANDERSON B HOLM G MERK K BJORKHOLM M
Citation: G. Grimfors et al., INCREASED SERUM CD4 SOLUBLE-ANTIGEN LEVEL IS ASSOCIATED WITH A POOR-PROGNOSIS IN ADULT HODGKINS-DISEASE, Blood, 84(10), 1994, pp. 10000642-10000642
A COMBINATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN MAY SYNERGISTICALLY IMPROVE THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: HELLSTROMLINDBERG E BIRGEGARD G CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G MERK K TANGEN JM WINQVIST I OST A
Citation: E. Hellstromlindberg et al., A COMBINATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN MAY SYNERGISTICALLY IMPROVE THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 11(3-4), 1993, pp. 221-228
DISEASE-RELATED DIFFERENCES IN ANTIBODY PATTERNS AGAINST EBV-ENCODED NUCLEAR ANTIGENS EBNA-1, EBNA-2 AND EBNA-6
Authors: LENNETTE ET RYMO L YADAV M MASUCCI G MERK K TIMAR L KLEIN G
Citation: Et. Lennette et al., DISEASE-RELATED DIFFERENCES IN ANTIBODY PATTERNS AGAINST EBV-ENCODED NUCLEAR ANTIGENS EBNA-1, EBNA-2 AND EBNA-6, European journal of cancer, 29A(11), 1993, pp. 1584-1589
ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (EACB) AS OUTPATIENT SALVAGE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA
Authors: OHRLING M BJORKHOLM M OSTERBORG A JULIUSSON G BJOREMAN M BRENNING G CARLSON K CELSING F GAHRTON G GRIMFORS G GRUBER A GYLLENHAMMAR H HAST R JOHANSSON B JARNMARK M KIMBY E LERNER R LINDER O MERK K PAUL C SIMONSSON B SMEDMYR B SVEDMYR E STALFELT AM UDEN AM OSBY E MELLSTEDT H
Citation: M. Ohrling et al., ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (EACB) AS OUTPATIENT SALVAGE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA, European journal of haematology, 51(1), 1993, pp. 45-49
LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA
Authors: WERSALL JP MASUCCI G HJELM AL RAGNHAMMAR P FAGERBERG J FRODIN JE MERK K LINDEMALM C ERICSON K KALIN B MELLSTEDT H
Citation: Jp. Wersall et al., LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 103-111
Risultati: 1-7 |